Atlas Trials

Copper 64Cu-DOTA-Daratumumab Positron Emission Tomography in Diagnosing Patients With Relapsed Multiple Myeloma

Clinical trial NCT03311828 · COMPLETED

Trial details

NCT number
NCT03311828
Sponsor
City of Hope Medical Center
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Recurrent Plasma Cell MyelomaPlasma Cell MyelomaSecondary Amyloidosis
Start date
2018-02-21
Primary completion
2020-01-22
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.